News Releases

Sandra K. Oza, M.D., M.A., Named Inaugural Assistant Dean for Learning Communities at Einstein
Montefiore Einstein Comprehensive Cancer Center Awarded FDA Grant for Clinical Trial on Experimental AML/MDS Treatment
Hope for Eradicating Dormant but Deadly Cancer Cells

Facts & Stats

Published Papers
NIH Research Funding
Full-time Faculty
Global Initiatives
Clinical and Research Centers

Expert List for Media

Vern L. Schramm

Vern L. Schramm, Ph.D.

Area(s) of expertise: BiochemistryEnzymesTranslational medicine

Dr. Schramm is a member of the National Academy of Sciences and associate editor of the Journal of the American Chemical Society.  His pioneering work in biochemistry has resulted in powerful new strategies for treating cancer,… Learn more

Einstein in the News

Less Snacking, More Satisfaction: Some Foods Boost Levels of an Ozempic-Like Hormone

Gary Schwartz, Ph.D., describes how GLP-1, a hormone that is released during digestion, acts to stimulate insulin and slow how quickly food moves through the stomach into the intestine. Dr. Schwartz is professor of medicine and of psychiatry and behavioral sciences and in the Dominick P. Purpura Department of Neuroscience at Einstein.

More coverage on Dr. Schwartz

Tirzepatide Has Huge Impact on Weight, Even After Loss From Lifestyle Change

Sriram Machineni, M.B.B.S., comments on the results of a study he co-authored on the effectiveness of a phase III trial for tirzepatide, a weight loss drug, which helped study participants lose a significant amount of weight following a diet and exercise program. Dr. Machineni is associate professor of medicine and director of the Fleischer Institute Medical Weight Center at Einstein and Montefiore.

Additional coverage includes Medscape

US News & World Report
Black Patients 42% More Likely to Die After High-Risk Surgery Than White Patients

Tracey Straker, M.D., comments on a study that found high-risk surgeries are more deadly for Black and Hispanic Americans than their white counterparts, noting that social determinants of health, such as lack of insurance, play a role in the disparities. Dr. Straker is professor and chief of anesthesiology at Einstein and Montefiore.

More coverage on Dr. Straker


When a Drug Becomes a Child’s Last Hope

Einstein scientist Vern Schramm, Ph.D., never imagined that his basic research into enzymes would intersect with a 2-year-old girl dying from an incurable form of blood cancer. He and that girl (Katie Lambertson, now a teenager) and her parents share their stories.

Watch more videos